Back to top

Image: Bigstock

Zacks Investment Ideas feature highlights: Assurant, Hippo, Horace Mann Educators, MGIC Investment, Slide Insurance and Oscar Health

Read MoreHide Full Article

For Immediate Release

Chicago, IL – September 22, 2026 – Today, Zacks Investment Ideas feature highlights Assurant (AIZ - Free Report) , Hippo Holdings (HIPO - Free Report) , Horace Mann Educators (HMN - Free Report) , MGIC Investment (MTG - Free Report) , Slide Insurance Holdings (SLDE - Free Report) and Oscar Health (OSCR - Free Report) .

5 Top Multi-Line Insurance Stocks to Buy as Interest Rates Stay Higher

Insurance stocks can be well positioned in a higher interest rate environment, particularly because insurers collect premiums upfront and invest that money until claims are paid.

Since many of those assets are held in bonds and other interest-bearing securities, elevated rates can boost investment income as maturing securities are reinvested at higher yields.

Adding to the appeal, the Zacks Insurance-Multi line Industry currently ranks in the top 32% of more than 240 Zacks industries.

That said, these five stocks from the top-rated Insurance-Multi line industry sport a Zacks Rank #1 (Strong Buy) thanks to improving earnings outlooks while trading at forward P/E multiples of under 15X. 

Assurant – AIZ

Stock Price: $277

Assurant provides protection products spanning connected devices, homes, automobiles, and commercial equipment. The company most recently delivered record Q2 results, with adjusted EBITDA rising 24% year over year to $479.2 million and adjusted EPS increasing 26% to $6.41. Assurant also raised its 2026 outlook following the strong first half.

With higher reinvestment yields providing an additional potential earnings tailwind, Assurant has the most robust top and bottom lines on the list. Annual sales are now expected to increase 8% this year to $13.92 billion, with EPS projected to rise nearly 13% to over $22 per share.

Hippo Holdings – HIPO

Stock Price: $31

Home insurer Hippo Holdings has also shown considerable operating momentum. Q2 gross written premiums surged 61% year over year to $482 million, while net income reached $10 million.

Furthermore, Hippo Holdings' combined ratio, a key measure of property-and-casualty underwriting profitability, improved four percentage points to 95.8%, with a mark below 100% indicating an underwriting profit.

That combination of premium growth, improving underwriting profitability, and potentially higher investment yields makes HIPO another attractive name to watch.

Horace Mann Educators – HMN

Stock Price: $48

Horace Mann Educators provides insurance and financial products primarily to teachers, administrators, and education support personnel in public and private schools.

Q2 core earnings hit a record $48.2 million, or $1.17 per share, while revenue rose 8% to $443.5 million. Plus, Horace Mann's combined ratio improved more than seven percentage points to 89.6%. 

Management subsequently raised full-year core EPS guidance to $4.60-$4.90, up from a prior range of $4.20-$4.50, and it's noteworthy that HMN offers a very generous annual dividend yield of roughly 3%.

MGIC Investment – MTG

Stock Price: $29

Mortgage insurer MGIC Investment posted Q2 net income of $182.1 million, or $0.86 per share, while generating a 14.5% return on equity.

The company has also been aggressively returning capital, authorizing an additional $750 million share repurchase program and raising its quarterly dividend by 13%.

MGIC's substantial investment portfolio can also benefit as it reinvests securities at higher yields, and MTG shares offer a respectable 2.29% annual dividend yield.

Slide Insurance Holdings – SLDE

Stock Price: $24

Property insurer Slide Insurance Holdings is generating some of the strongest growth of the group. Q2 gross premiums written rose 16.7% to $508 million, revenue jumped nearly 48%, and net income surged 92% to $134.9 million. Plus, its combined ratio improved to an exceptionally strong 57.6%.

Slide also maintained its 2026 net income outlook of $455-$470 million, providing further support. Along with having the most affordable stock price on the list, SLDE has the cheapest P/E valuation at 6X forward earnings. 

Honorable Mention & Bottom Line

Multi-line health insurer Oscar Health deserves an honorable mention with its own Zacks Rank #1 (Strong Buy). With its stock trading around $31 a share and 18X forward earnings, Oscar reported record first-half profitability and raised its 2026 outlook after Q2 revenue surged to roughly $4.9 billion from $2.9 billion a year earlier.

Higher rates aren't automatically positive for every insurer, as underwriting losses and claims trends remain major earnings drivers. Still, these highly ranked insurance stocks combine improving operating fundamentals with the potential for stronger investment income, while their strong buy ratings highlight favorable earnings estimate trends.

Why Haven't You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.

Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.

Published in